José González

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

Miguel Á. Sanz, Pau Montesinos, Chelo Rayón et al. · Blood · 2010 · 336 citations · Full text

Medicine, Oncology, Pharmacology +16

Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery

Maura Marcucci, Thomas Painter, David Conen et al. · Annals of Internal Medicine · 2023 · 156 citations · Full text

Medicine, Perioperative Medicine, Surgery +17

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens

Pau Montesinos, Chelo Rayón, Edo Vellenga et al. · Blood · 2010 · 143 citations · Full text

Medicine, Hematology, Oncology +14

Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-<i>Trans</i>-Retinoic Acid and Anthracycline-Based Chemotherapy

Pau Montesinos, José D. González, José González et al. · Journal of Clinical Oncology · 2010 · 72 citations · Full text

Medicine, Hematology, Oncology +15

Acetylator polymorphism in human colorectal carcinoma.

J. M. Ladero, José González, J. Benítez et al. · PubMed · 1991 · 68 citations

Medicine, Genetics, Oncology +12